Register or Login To Download This Patent As A PDF
| United States Patent Application |
20070033660
|
| Kind Code
|
A1
|
|
Palti; Yoram
|
February 8, 2007
|
METHOD FOR SELECTIVELY DESTROYING DIVIDING CELLS
Abstract
When dividing cells with polarizable intracellular members exist within
living tissue, those cells can be destroyed by positioning insulated
electrodes in relation to the living tissue and applying an alternating
electric potential across the first and second insulated electrodes, so
that the living tissue is subjected to an alternating electric field.
Passage of the electric field through the dividing cells in late anaphase
or telophase results in the formation of a non-homogeneous electric field
with an increased density electric field in a region of cleavage furrow
of the dividing cells. The non-homogeneous electric field is of
sufficient intensity to move the intracellular members toward the
cleavage furrow until the intracellular members disrupt the cleavage
furrow.
| Inventors: |
Palti; Yoram; (Haifa, IL)
|
| Correspondence Address:
|
PROSKAUER ROSE LLP;PATENT DEPARTMENT
1585 BROADWAY
NEW YORK
NY
10036-8299
US
|
| Serial No.:
|
470405 |
| Series Code:
|
11
|
| Filed:
|
September 6, 2006 |
| Current U.S. Class: |
800/3 |
| Class at Publication: |
800/003 |
| International Class: |
G01N 33/00 20060101 G01N033/00 |
Claims
1. A method for selectively destroying dividing cells in living tissue,
the dividing cells having polarizable intracellular members, the method
comprising the steps of: providing an apparatus having: a first insulated
electrode having a first conductor; a second insulated electrode having a
second conductor; and an electric field source for applying an
alternating electric potential across the first and second conductors;
positioning the first and second insulated electrodes in relation to the
living tissue; and subjecting the living tissue to the alternating
electric field, wherein passage of the electric field through the
dividing cells in late anaphase or telophase results in the formation of
a non-homogeneous electric field with an increased density electric field
in a region of cleavage furrow of the dividing cells, the non-homogeneous
electric field being of sufficient intensity to move the intracellular
members toward the cleavage furrow until the intracellular members
disrupt the cleavage furrow.
2. The method of claim 1, wherein the electric field is of sufficient
frequency so that the non-homogeneous electric field produced in the
dividing cells defines electric field lines which generally converge at a
region of the cleavage furrow, thereby defining the increased density
electric field, resulting in destruction of the dividing cells as a
result of the polarizable intracellular members movement toward the
furrow.
3. The method of claim 1, wherein positioning the first and second
electrodes comprises: positioning dielectric members of each conductor
against the living tissue to form a capacitor.
4. The method of claim 1, wherein subjecting the living tissue to the
alternating electric field comprises applying an alternating electric
potential having a frequency of between about 50 kHz to about 500 kHz.
5. The method of claim 1, wherein the dividing cells comprise a first
sub-cell and a second sub-cell with the cleavage furrow connecting the
two in late anaphase or telophase.
6. The method of claim 1, further comprising the step of: rotating the
electric field source relative to the living tissue.
7. The method of claim 1, wherein movement of the intracellular members
toward the cleavage furrow increases pressure being exerted on the
cleavage furrow, the increased pressure causing the region of the
cleavage furrow to expand resulting in the cleavage furrow breaking apart
and causing destruction of the dividing cells.
Description
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application is a divisional of U.S. patent application Ser.
No. 10/263,329, filed Oct. 2, 2002.
TECHNICAL FIELD
[0002] This invention concerns selective destruction of rapidly dividing
cells, and more particularly, to an apparatus for selectively destroying
dividing cells by applying an electric field having certain prescribed
characteristics.
BACKGROUND
[0003] All living organisms proliferate by cell division, including cell
cultures, microorganisms (such as bacteria, mycoplasma, yeast, protozoa,
and other single-celled organisms), fungi, algae, plant cells, etc.
Dividing cells of organisms can be destroyed, or their proliferation
controlled, by methods that are based on the sensitivity of the dividing
cells of these organisms to certain agents. For example, certain
antibiotics stop the multiplication process of bacteria.
[0004] The process of eukaryotic cell division is called "mitosis", which
involves nice distinct phases (see Darnell et al., Molecular Cell
Biology, New York: Scientific American Books, 1986, p. 149). During
interphase, the cell replicates chromosomal DNA, which begins condensing
in early prophase. At this point, centrioles (each cell contains 2) begin
moving towards opposite poles of the cell. In middle prophase, each
chromosome is composed of duplicate chromatids. Microtubular spindles
radiate from regions adjacent to the centrioles, which are closer to
their poles. By late prophase, the centrioles have reached the poles, and
some spindle fibers extend to the center of the cell, while others extend
from the poles to the chromatids. The cells then move into metaphase,
when the chromosomes move toward the equator of the cell and align in the
equatorial plane. Next is early anaphase, during which time daughter
chromatids separate from each other at the equator by moving along the
spindle fibers toward a centromere at opposite poles. The cell begins to
elongate along the axis of the pole; the pole-to-pole spindles also
elongate. Late anaphase occurs when the daughter chromosomes (as they are
not called) each reach their respective opposite poles. At this point,
cytokinesis begins as the cleavage furrow begins to form at the equator
of the cell. In other words, late anaphase is the point at which pinching
the cell membrane begins. During telophase, cytokinesis is nearly
complete and spindles disappear. Only a relatively narrow membrane
connection joins the two cytoplasms. Finally, the membranes separate
fully, cytokinesis is complete and the cell returns to interphase.
[0005] In meiosis, the cell undergoes a second division, involving
separation of sister chromosomes to opposite poles of the cell along
spindle fibers, followed by formation of a cleavage furrow and cell
division. However, this division is not preceded by chromosome
replication, yielding a haploid germ cell.
[0006] Bacteria also divide by chromosome replication, followed by cell
separation. However, since the daughter chromosomes separate by
attachment to membrane components; there is no visible apparatus that
contributes to cell division as in eukaryotic cells.
[0007] It is well known that tumors, particularly malignant or cancerous
tumors, grow uncontrollably compared to normal tissue. Such expedited
growth enables tumors to occupy an ever-increasing space and to damage or
destroy tissue adjacent thereto. Furthermore, certain cancers are
characterized by an ability to transmit cancerous "seeds", including
single cells or small cell clusters (metastases), to new locations where
the metastatic cancer cells grow into additional tumors.
[0008] The rapid growth of tumors, in general, and malignant tumors in
particular, as described above, is the result of relatively frequent cell
division or multiplication of these cells compared to normal tissue
cells. The distinguishably frequent cell division of cancer cells is the
basis for the effectiveness of existing cancer treatments, e.g.,
irradiation therapy and the use of various chemo-therapeutic agents. Such
treatments are based on the fact that cells undergoing division are more
sensitive to radiation and chemo-therapeutic agents than non-dividing
cells. Because tumors cells divide much more frequently than normal
cells, it is possible, to a certain extent, to selectively damage or
destroy tumor cells by radiation therapy and/or chemotherapy. The actual
sensitivity of cells to radiation, therapeutic agents, etc., is also
dependent on specific characteristics of different types of normal or
malignant cell types. Thus, unfortunately, the sensitivity of tumor cells
is not sufficiently higher than that many types of normal tissues. This
diminishes the ability to distinguish between tumor cells and normal
cells, and therefore, existing cancer treatments typically cause
significant damage to normal tissues, thus limiting the therapeutic
effectiveness of such treatments. Furthermore, the inevitable damage to
other tissue renders treatments very traumatic to the patients and,
often, patients are unable to recover from a seemingly successful
treatment. Also, certain types of tumors are not sensitive at all to
existing methods of treatment.
[0009] There are also other methods for destroying cells that do not rely
on radiation therapy or chemotherapy alone. For example, ultrasonic and
electrical methods for destroying tumor cells can be used in addition to
or instead of conventional treatments. Electric fields and currents have
been used for medical purposes for many years. The most common is the
generation of electric currents in a human or animal body by application
of an electric field by means of a pair of conductive electrodes between
which a potential difference is maintained. These electric currents are
used either to exert their specific effects, i.e., to stimulate excitable
tissue, or to generate heat by flowing in the body since it acts as a
resistor. Examples of the first type of application include the
following: cardiac defibrillators, peripheral nerve and muscle
stimulators, brain stimulators, etc. Currents are used for heating, for
example, in devices for tumor ablation, ablation of malfunctioning
cardiac or brain tissue, cauterization, relaxation of muscle rheumatic
pain and other pain, etc.
[0010] Another use of electric fields for medical purposes involves the
utilization of high frequency oscillating fields transmitted from a
source that emits an electric wave, such as an RF wave or a microwave
source that is directed at the part of the body that is of interest
(i.e., target). In these instances, there is no electric energy
conduction between the source and the body; but rather, the energy is
transmitted to the body by radiation or induction. More specifically, the
electric energy generated by the source reaches the vicinity of the body
via a conductor and is transmitted from it through air or some other
electric insulating material to the human body.
[0011] In a conventional electrical method, electrical current is
delivered to a region of the target tissue using electrodes that are
placed in contact with the body of the patient. The applied electrical
current destroys substantially all cells in the vicinity of the target
tissue. Thus, this type of electrical method does not discriminate
between different types of cells within the target tissue and results in
the destruction of both tumor cells and normal cells.
[0012] Electric fields that can be used in medical applications can thus
be separated generally into two different modes. In the first mode, the
electric fields are applied to the body or tissues by means of conducting
electrodes. These electric fields can be separated into two types, namely
(1) steady fields or fields that change at relatively slow rates, and
alternating fields of low frequencies that induce corresponding electric
currents in the body or tissues, and (2) high frequency alternating
fields (above 1 MHz) applied to the body by means of the conducting
electrodes. In the second mode, the electric fields are high frequency
alternating fields applied to the body by means of insulated electrodes.
[0013] The first type of electric field is used, for example, to stimulate
nerves and muscles, pace the heart, etc. In fact, such fields are used in
nature to propagate signals in nerve and muscle fibers, central nervous
system (CNS), heart, etc. The recording of such natural fields is the
basis for the ECG, EEG, EMG, ERG, etc. The field strength in these
applications, assuming a medium of homogenous electric properties, is
simply the voltage applied to the stimulating/recording electrodes
divided by the distance between them. These currents can be calculated by
Ohm's law and can have dangerous stimulatory effects on the heart and CNS
and can result in potentially harmful ion concentration changes. Also, if
the currents are strong enough, they can cause excessive heating in the
tissues. This heating can be calculated by the power dissipated in the
tissue (the product of the voltage and the current).
[0014] When such electric fields and currents are alternating, their
stimulatory power, on nerve, muscle, etc., is an inverse function of the
frequency. At frequencies above 1-10 kHz, the stimulation power of the
fields approaches zero. This limitation is due to the fact that
excitation induced by electric stimulation is normally mediated by
membrane potential changes, the rate of which is limited by the RC
properties (time constants on the order of 1 ms) of the membrane.
[0015] Regardless of the frequency, when such current inducing fields are
applied, they are associated with harmful side effects caused by
currents. For example, one negative effect is the changes in ionic
concentration in the various "compartments" within the system, and the
harmful products of the electrolysis taking place at the electrodes, or
the medium in which the tissues are imbedded. The changes in ion
concentrations occur whenever the system includes two or more
compartments between which the organism maintains ion concentration
differences. For example, for most tissues, [Ca.sup.++] in the
extracellular fluid is about 2.times.10.sup.-3 M, while in the cytoplasm
of typical cells its concentration can be as low as 10.sup.-7 M. A
current induced in such a system by a pair of electrodes, flows in part
from the extracellular fluid into the cells and out again into the
extracellular medium. About 2% of the current flowing into the cells is
carried by the Ca.sup.++ ions. In contrast, because the concentration of
intracellular Ca.sup.-+ is much smaller, only a negligible fraction of
the currents that exits the cells is carried by these ions. Thus,
Ca.sup.++ ions accumulate in the cells such that their concentrations in
the cells increases, while the concentration in the extracellular
compartment may decrease. These effects are observed for both DC and
alternating currents (AC). The rate of accumulation of the ions depends
on the current intensity ion mobilities, membrane ion conductance, etc.
An increase in [Ca.sup.++] is harmful to most cells and if sufficiently
high will lead to the destruction of the cells. Similar considerations
apply to other ions. In view of the above observations, long term current
application to living organisms or tissues can result in significant
damage. Another major problem that is associated with such electric
fields, is due to the electrolysis process that takes place at the
electrode surfaces. Here charges are transferred between the metal
(electrons) and the electrolytic solution (ions) such that charged active
radicals are formed. These can cause significant damage to organic
molecules, especially macromolecules and thus damage the living cells and
tissues.
[0016] In contrast, when high frequency electric fields, above 1 MHz and
usually in practice in the range of GHz, are induced in tissues usually
by means of insulated electrodes or transmission of EM waves, the
situation is quite different. These type of fields generate only
capacitive or displacement currents, rather than the conventional charge
conducting currents. Under the effect of this type of field, living
tissues behave mostly according to their dielectric properties rather
than their electric conductive properties. Therefore, the dominant field
effect is that due to dielectric losses and heating. Thus, it is widely
accepted that in practice, the meaningful effects of such fields on
living organisms, are only those due to their heating effects, i.e., due
to dielectric losses.
[0017] In U.S. Pat. No. 6,043,066 ('066) to Mangano, a method and device
are presented which enable discrete objects having a conducting inner
core, surrounded by a dielectric membrane to be selectively inactivated
by electric fields via irreversible breakdown of their dielectric
membrane. One potential application for this is in the selection and
purging of certain biological cells in a suspension. According to the
'066 patent, an electric field is applied for targeting selected cells to
cause breakdown of the dielectric membranes of these tumor cells, while
purportedly not adversely affecting other desired subpopulations of
cells. The cells are selected on the basis of intrinsic or induced
differences in a characteristic electroporation threshold. The
differences in this threshold can depend upon a number of parameters,
including the difference in cell size.
[0018] The method of the '066 patent is therefore based on the assumption
that the electroporation threshold of tumor cells is sufficiently
distinguishable from that of normal cells because of differences in cell
size and differences in the dielectric properties of the cell membranes.
Based upon this assumption, the larger size of many types of tumor cells
makes these cells more susceptible to electroporation and thus, it may be
possible to selectively damage only the larger tumor cell membranes by
applying an appropriate electric field. One disadvantage of this method
is that the ability to discriminate is highly dependent upon cell type,
for example, the size difference between normal cells and tumor cells is
significant only in certain types of cells. Another drawback of this
method is that the voltages which are applied can damage some of the
normal cells and may not damage all of the tumor cells because the
differences in size and membrane dielectric properties are largely
statistical and the actual cell geometries and dielectric properties can
vary significantly.
[0019] What is needed in the art and has heretofore not been available is
an apparatus for killing dividing cells, wherein the apparatus better
discriminates between dividing cells, including single-celled organisms,
and non-dividing cells and is capable of selectively destroying the
dividing cells or organisms with substantially no affect on the
non-dividing cells or organisms.
SUMMARY
[0020] An apparatus for use in a number of different applications for
selectively destroying cells undergoing growth and division is provided.
This includes, cell, particularly tumor cells, in living tissue and
single-celled organisms. The apparatus can be incorporated into a number
of different configurations (e.g., as a skin patch or embedded internally
within the body) to eliminate or control the growth of such living tissue
or organisms.
[0021] A major use of the present apparatus is in the treatment of tumors
by selective destruction of tumor cells with substantially no affect on
normal tissue cells, and thus, the exemplary apparatus is described below
in the context of selective destruction of tumor cells. It should be
appreciated however, that for purpose of the following description, the
term "cell" may also refer to a single-celled organism (eubacteria,
bacteria, yeast, protozoa), multi-celled organisms (fungi, algae, mold),
and plants as or parts thereof that are not normally classified as
"cells". The exemplary apparatus enables selective destruction of cells
undergoing division in a way that is more effective and more accurate
(e.g., more adaptable to be aimed at specific targets) than existing
methods. Further, the present apparatus causes minimal damage, if any, to
normal tissue and, thus, reduces or eliminates many side-effects
associated with existing selective destruction methods, such as radiation
therapy and chemotherapy. The selective destruction of dividing cells
using the present apparatus does not depend on the sensitivity of the
cells to chemical agents or radiation. Instead, the selective destruction
of dividing cells is based on distinguishable geometrical and structural
characteristics of cells undergoing division, in comparison to
non-dividing cells, regardless of the cell geometry of the type of cells
being treated.
[0022] According to one exemplary embodiment, cell geometry-dependent
selective destruction of living tissue is performed by inducing a
non-homogenous electric field in the cells using an electronic apparatus.
[0023] It has been observed by the present inventor that, while different
cells in their non-dividing state may have different shapes, e.g.,
spherical, ellipsoidal, cylindrical, "pancake-like", etc., the division
process of practically all cells is characterized by development of a
"cleavage furrow" in late anaphase and telophase. This cleavage furrow is
a slow constriction of the cell membrane (between the two sets of
daughter chromosomes) which appears microscopically as a growing cleft
(e.g., a groove or notch) that gradually separates the cell into two new
cells. During the division process, there is a transient period
(telophase) during which the cell structure is basically that of two
sub-cells interconnected by a narrow "bridge" formed of the cell
material. The division process is completed when the "bridge" between the
two sub-cells is broken. The selective destruction of tumor cells using
the present electronic apparatus utilizes this unique geometrical feature
of dividing cells.
[0024] When a cell or a group of cells are under natural conditions or
environment, i.e., part of a living tissue, they are disposed surrounded
by a conductive environment consisting mostly of an electrolytic
inter-cellular fluid and other cells that are composed mostly of an
electrolytic intra-cellular liquid. When an electric field is induced in
the living tissue, by applying an electric potential across the tissue,
an electric field is formed in the tissue and the specific distribution
and configuration of the electric field lines defines the paths of
electric currents in the tissue, if currents are in fact induced in the
tissue. The distribution and configuration of the electric field is
dependent on various parameters of the tissue, including the geometry and
the electric properties of the different tissue components, and the
relative conductivities, capacities and dielectric constants (that may be
frequency dependent) of the tissue components.
[0025] The electric current flow pattern for cells undergoing division is
very different and unique as compared to non-dividing cells. Such cells
including first and second sub-cells, namely an "original" cell and a
newly formed cell, that are connected by a cytoplasm "bridge" or "neck".
The currents penetrate the first sub-cell through part of the membrane
("the current source pole"); however, they do not exit the first sub-cell
through a portion of its membrane closer to the opposite pole ("the
current sink pole"). Instead, the lines of current flow converge at the
neck or cytoplasm bridge, whereby the density of the current flow lines
is greatly increased. A corresponding, "mirror image", process that takes
place in the second sub-cell, whereby the current flow lines diverge to a
lower density configuration as they depart from the bridge, and finally
exit the second sub-cell from a part of its membrane closes to the
current sink.
[0026] When a polar or a polarizable object is placed in a non-uniform
converging or diverging field, electric forces act on it and pull it
towards the higher density electric field lines. In the case of dividing
cell, electric forces are exerted in the direction of the cytoplasm
bridge between the two cells. Since all intercellular organelles are
polarizable, and most macromolecules are polar (have a dipole moment)
they are all force towards the bridge between the two cells. The field
polarity is irrelevant to the direction of the force and, therefore, an
alternating electric having specific properties can be used to produce
substantially the same effect. It will also be appreciated that the
concentrated electric field present in or near the bridge or neck portion
in itself exerts strong forces on charges and natural dipoles and can
lead to the disruption of structures associated with these members.
[0027] The movement of the cellular organelles towards the bridge disrupts
the cell structure and results in increased pressure in the vicinity of
the connecting bridge membrane. This pressure of the organelles on the
bridge membrane is expected to break the bridge membrane and, thus, it is
expected that the dividing cell will "explode" in response to this
pressure. The ability to break the membrane and disrupt other cell
structures can be enhanced by applying a pulsating alternating electric
field that has a frequency from about 50 kHz to about 500 kHz. When this
type of electric field is applied to the tissue, the forces exerted on
the intercellular organelles have a "hammering" effect, whereby force
pulses (or beats) are applied to the organelles numerous times per
second, enhancing the movement of organelles of different sizes and
masses towards the bridge (or neck) portion from both of the sub-cells,
thereby increasing the probability of breaking the cell membrane at the
bridge portion. The forces exerted on the intracellular organelles also
affect the organelles themselves and may collapse or break the
organelles.
[0028] According to one exemplary embodiment, the apparatus for applying
the electric field is an electronic apparatus that generates the desired
electric signals in the shape of waveforms or trains of pulses. The
electronic apparatus includes a generator that generates an alternating
voltage waveform at frequencies in the range from about 50 kHz to about
500 kHz. The generator is operatively connected to conductive leads which
are connected at their other ends to insulated conductors/electrodes
(also referred to as isolects) that are activated by the generated
waveforms. The insulated electrodes consist of a conductor in contact
with a dielectric (insulating layer) that is in contact with the
conductive tissue, thus forming a capacitor. The electric fields that are
generated by the present apparatus can be applied in several different
modes depending upon the precise treatment application.
[0029] In one exemplary embodiment, the electric fields are applied by
external insulated electrodes which are constructed so that the applied
electric fields can be of a local type or of a widely distributed type.
This embodiment is designed to treat skin tumors and lesions that are
close to the skin surface. According to this embodiment, the insulated
electrodes can be incorporated into a skin patch that is applied to a
skin surface. The skin patch can be a self-adhesive flexible patch and
can include one or more pairs of the insulated electrodes.
[0030] According to another embodiment, the apparatus is used in an
internal type application in that the insulated electrodes are in the
form of plates, wires, etc., that are inserted subcutaneously or deeper
within the body so as to generate an electric field having the above
desired properties at a target area (e.g., a tumor).
[0031] Thus, the present apparatus utilizes electric fields that fall into
a special intermediate category relative to previous high and low
frequency applications in that the present electric fields are
bio-effective fields that have no meaningful stimulatory effects and no
thermal effects. Advantageously, when non-dividing cells are subjected to
these electric fields, there is no effect on the cells; however, the
situation is much different when dividing cells are subjected to the
present electric fields. Thus, the present electronic apparatus and the
generated electric fields target dividing cells, such as tumors or the
like, and do not target non-dividing cells that is found around in
healthy tissue surrounding the target area. Furthermore, since the
present apparatus utilizes insulated electrodes, the above mentioned
negative effects, obtained when conductive electrodes are used, i.e., ion
concentration changes in the cells and the formation of harmful agents by
electrolysis, do not occur with the present apparatus. This is because,
in general, no actual transfer of charges takes place between the
electrodes and the medium, and there is no charge flow in the medium
where the currents are capacitive.
[0032] It should be appreciated that the present electronic apparatus can
also be used in applications other than treatment of tumors in the living
body. In fact, the selective destruction utilizing the present apparatus
can be used in conjunction with any organism that proliferates division
and multiplication, for example, tissue cultures, microorganisms, such as
bacteria, mycoplasma, protozoa, fungi, algae, plant cells, etc. Such
organisms divide by the formation of a groove or cleft as described
above. As the groove or cleft deepens, a narrow bridge is formed between
the two parts of the organism, similar to the bridge formed between the
sub-cells of dividing animal cells. Since such organisms are covered by a
membrane having a relatively low electric conductivity, similar to an
animal cell membrane described above, the electric field lines in a
dividing organism converge at the bridge connecting the two parts of the
dividing organism. The converging field lines result in electric forces
that displace polarizable elements within the dividing organism.
[0033] The above, and other objects, features and advantages of the
present apparatus will become apparent from the following description
read in conjunction with the accompanying drawings, in which like
reference numerals designate the same elements.
BRIEF DESCRIPTION OF THE DRAWING FIGURES
[0034] FIGS. 1A-1E are simplified, schematic, cross-sectional,
illustrations of various stages of a cell division process;
[0035] FIGS. 2A and 2B are schematic illustrations of a non-dividing cell
being subjected to an electric field;
[0036] FIGS. 3A, 3B and 3C are schematic illustrations of a dividing cell
being subjected to an electric field according to one exemplary
embodiment, resulting in destruction of the cell (FIG. 3C) in accordance
with one exemplary embodiment;
[0037] FIG. 4 is a schematic illustration of a dividing cell at one stage
being subject to an electric field;
[0038] FIG. 5 is a schematic diagram of an apparatus for applying an
electric according to one exemplary embodiment for selectively destroying
cells;
[0039] FIG. 6 is a simplified schematic diagram of an equivalent electric
circuit of insulated electrodes of the apparatus of FIG. 5;
[0040] FIG. 7 is a schematic illustration of a skin patch incorporating
the apparatus of FIG. 5 and for placement on a skin surface for treating
a tumor or the like;
[0041] FIG. 8 is a schematic illustration of the insulated electrodes
implanted within the body for treating a tumor or the like;
[0042] FIG. 9 is a schematic illustration of the insulated electrodes
implanted within the body for treating a tumor or the like;
[0043] FIGS. 10A-10D are schematic illustrations of various constructions
of the insulated electrodes of the apparatus of FIG. 5;
[0044] FIG. 11 is a schematic illustration of two insulated electrodes
being arranged about a human torso for treatment of a tumor container
within the body, e.g., a tumor associated with lung cancer;
[0045] FIGS. 12A-12C are schematic illustrations of various insulated
electrodes with and without protective members formed as a part of the
construction thereof; and
[0046] FIG. 13 is a schematic illustration of insulated electrodes that
are arranged for focusing the electric field at a desired target while
leaving other areas in low field density (i.e., protected areas).
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0047] Reference is made to FIGS. 1A-1E which schematically illustrate
various stages of a cell division process. FIG. 1A illustrates a cell 10
at its normal geometry, which can be generally spherical (as illustrated
in the drawings), ellipsoidal, cylindrical, "pancake-like" or any other
cell geometry, as is known in the art. FIGS. 1B-1D illustrate cell 10
during different stages of its division process, which results in the
formation of two new cells 18 and 20, shown in FIG. 1E.
[0048] As shown in FIGS. 1B-1D, the division process of cell 10 is
characterized by a slowly growing cleft 12 which gradually separates cell
10 into two units, namely sub-cells 14 and 16, which eventually evolve
into new cells 18 and 20 (FIG. 1E). A shown specifically in FIG. 1D, the
division process is characterized by a transient period during which the
structure of cell 10 is basically that of the two sub-cells 14 and 16
interconnected by a narrow "bridge" 22 containing cell material
(cytoplasm surrounded by cell membrane).
[0049] Reference is now made to FIGS. 2A and 2B, which schematically
illustrate non-dividing cell 10 being subjected to an electric field
produced by applying an alternating electric potential, at a relatively
low frequency and at a relatively high frequency, respectively. Cell 10
includes intracellular organelles, e.g., a nucleus 30. Alternating
electric potential is applied across electrodes 28 and 32 that can be
attached externally to a patient at a predetermined region, e.g., in the
vicinity of the tumor being treated. When cell 10 is under natural
conditions, i.e., part of a living tissue, it is disposed in a conductive
environment (hereinafter referred to as a "volume conductor") consisting
mostly of electrolytic inter-cellular liquid. When an electric potential
is applied across electrodes 28 and 32, some of the field lines of the
resultant electric field (or the current induced in the tissue in
response to the electric field) penetrate the cell 10, while the rest of
the field lines (or induced current) flow in the surrounding medium. The
specific distribution of the electric field lines, which is substantially
consistent with the direction of current flow in this instance, depends
on the geometry and the electric properties of the system components,
e.g., the relative conductivities and dielectric constants of the system
components, that can be frequency dependent. For low frequencies, e.g.,
frequencies lower than 10 kHz, the conductance properties of the
components completely dominate the current flow and the field
distribution, and the field distribution is generally as depicted in FIG.
2A. At higher frequencies, e.g., at frequencies of between 10 kHz and 1
MHz, the dielectric properties of the components becomes more significant
and eventually dominate the field distribution, resulting in field
distribution lines as depicted generally in FIG. 2B.
[0050] For constant (i.e., DC) electric fields or relatively low frequency
alternating electric fields, for example, frequencies under 10 kHz, the
dielectric properties of the various components are not significant in
determining and computing the field distribution. Therefore, as a first
approximation, with regard to the electric field distribution, the system
can be reasonably represented by the relative impedances of its various
components. Using this approximation, the intercellular (i.e.,
extracellular) fluid and the intracellular fluid each has a relatively
low impedance, while the cell membrane 11 has a relatively high
impedance. Thus, under low frequency conditions, only a fraction of the
electric field lines (or currents induced by the electric field)
penetrate membrane 11 of the cell 10. At relatively high frequencies
(e.g., 10 kHz-1 MHz), in contrast, the impedance of membrane 11 relative
to the intercellular and intracellular fluids decreases, and thus, the
fraction of currents penetrating the cells increases significantly. It
should be noted that at very high frequencies, i.e., above 1 MHz, the
membrane capacitance can short the membrane resistance and, therefore,
the total membrane resistance can become negligible.
[0051] In any of the embodiments described above, the electric field lines
(or induced currents) penetrate cell 10 from a portion of the membrane 11
closest to one of the electrodes generating the current, e.g., closest to
positive electrode 28 (also referred to herein as "source"). The current
flow pattern across cell 10 is generally uniform because, under the above
approximation, the field induced inside the cell is substantially
homogeneous. The currents exit cell 10 through a portion of membrane 11
closest to the opposite electrode, e.g., negative electrode 32 (also
referred to herein as "sink").
[0052] The distinction between field lines and current flow can depend on
a number of factors, for example, on the frequency of the applied
electric potential and on whether electrodes 28 and 32 are electrically
insulated. For insulated electrodes applying a DC or low frequency
alternating voltage, there is practically no current flow along the lines
of the electric field. At higher frequencies, the displacement currents
are induced in the tissue due to charging and discharging of the
electrode insulation and the cell membranes (which act as capacitors to a
certain extent), and such currents follow the lines of the electric
field. Fields generated by non-insulated electrodes, in contrast, always
generate some form of current flow, specifically, DC or low frequency
alternating fields generate conductive current flow along the field
lines, and high frequency alternating fields generate both conduction and
displacement currents along the field lines. It should be appreciated,
however, that movement of polarizable intracellular organelles according
to the present invention (as described below) is not dependent on actual
flow of current and, therefore, both insulated and non-insulated
electrodes can be used efficiently. Several advantages of insulated
electrodes are that they have lower power consumption and cause less
heating of the treated regions.
[0053] According to one exemplary embodiment of the present invention, the
electric fields that are used are alternating fields having frequencies
that are in the range from about 50 kHz to about 500 kHz, and preferably
from about 100 kHz to about 300 kHz. For ease of discussion, these type
of electric fields are also referred to below as "TC fields", which is an
abbreviation of "Tumor Curing electric fields", since these electric
fields fall into an intermediate category (between high and low frequency
ranges) that have bio-effective field properties while having no
meaningful stimulatory and thermal effects. These frequencies are
sufficiently low so that the system behavior is determined by the
system's Ohmic (conductive) properties but sufficiently high enough not
to have any stimulation effect on excitable tissues. Such a system
consists of two types of elements, namely, the intercellular, or
extracellular fluid, or medium and the individual cells. The
intercellular fluid is mostly an electrolyte with a specific resistance
of about 40-100 Ohm*cm. As mentioned above, the cells are characterized
by three elements, namely (1) a thin, highly electric resistive membrane
that coats the cell; (2) internal cytoplasm that is mostly an electrolyte
that contains numerous macromolecules and micro-organelles, including the
nucleus; and (3) membranes, similar in their electric properties to the
cell membrane, cover the micro-organelles.
[0054] When this type of system is subjected to the present TC fields
(e.g., alternating electric fields in the frequency range of 100 kHz-300
kHz) most of the lines of the electric field and currents tend away from
the cells because of the high resistive cell membrane and therefore the
lines remain in the extracellular conductive medium. In the above recited
frequency range, the actual fraction of electric field or currents that
penetrates the cells is a strong function of the frequency.
[0055] FIG. 3 schematically depicts the resulting field distribution in
the system. As illustrated, the lines of force, which also depict the
lines of potential current flow across the cell volume mostly in parallel
with the undistorted lines of force (the main direction of the electric
field). In other words, the field inside the cells is mostly homogeneous.
In practice, the fraction of the field or current that penetrates the
cells is determined by the cell membrane impedance value relative to that
of the extracellular fluid. Since the equivalent electric circuit of the
cell membrane is that of a resistor and capacitor in parallel, the
impedance is a function of the frequency. The higher the frequency, the
lower the impedance, the larger the fraction of penetrating current and
the smaller the field distortion.
[0056] As previously mentioned, when cells are subjected to relatively
weak electric fields and currents that alternate at high frequencies,
such as the present TC fields having a frequency in the range of 50
kHz-500 kHz, they have no effect on the non-dividing cells. While the
present TC fields have no detectable effect on such systems, the
situation becomes different in the presence of dividing cells.
[0057] Reference is now made to FIGS. 3A-3C which schematically illustrate
the electric current flow pattern in cell 10 during its division process,
under the influence of alternating fields (TC fields) in the frequency
range from about 100 kHz to about 300 kHz in accordance with one
exemplary embodiment. The field lines or induced currents penetrate cell
10 through a part of the membrane of sub-cell 16 closer to electrode 28.
However, they do not exit through the cytoplasm bridge 22 that connects
sub-cell 16 with the newly formed yet still attached sub-cell 14, or
through a part of the membrane in the vicinity of the bridge 22. Instead,
the electric field or current flow lines--that are relatively widely
separated in sub-cell 16--converge as they approach bridge 22 (also
referred to as "neck" 22) and, thus, the current/field line density
within neck 22 is increased dramatically. A "mirror image" process takes
place in sub-cell 14, whereby the converging field lines in bridge 22
diverge as they approach the exit region of sub-cell 14.
[0058] It should be appreciated by persons skilled in the art that
homogeneous electric fields do not exert a force on electrically neutral
objects, i.e., objects having substantially zero net charge, although
such objects can become polarized. However, under a non-uniform,
converging electric field, as shown in FIGS. 3A-3C, electric forces are
exerted on polarized objects, moving them in the direction of the higher
density electric field lines. It will be appreciated that the
concentrated electric field that is present in the neck or bridge area in
itself exerts strong forces on charges and natural dipoles and can
disrupt structures that are associated therewith.
[0059] In the configuration of FIGS. 3A and 3B, the direction of movement
of polarized objects is towards the higher density electric field lines,
i.e., towards the cytoplasm bridge 22 between sub-cells 14 and 16. It is
known in the art that all intracellular organelles, for example, nuclei
24 and 26 of sub-cells 14 and 16, respectively, are polarizable and,
thus, such intracellular organelles are electrically forced in the
direction of the bridge 22. Since the movement is always from lower
density currents to the higher density currents, regardless of the field
polarity, the forces applied by the alternating electric field to
organelles, such as nuclei 24 and 26, are always in the direction of
bridge 22. A comprehensive description of such forces and the resulting
movement of macromolecules of intracellular organelles, a phenomenon
referred to as "dielectrophoresis" is described extensively in
literature, e.g., in C. L. Asbury & G. van den Engh, Biophys. J. 74,
1024-1030, 1998, the disclosure of which is hereby incorporated by
reference in its entirety.
[0060] The movement of the organelles 24 and 26 towards the bridge 22
disrupts the structure of the dividing cell and, eventually, the pressure
of the converging organelles on bridge membrane 22 results in the
breakage of cell membrane 11 at the vicinity of the bridge 22, as shown
schematically in FIG. 3C. The ability to break membrane 11 at bridge 22
and to otherwise disrupt the cell structure and organization can be
enhanced by applying a pulsating AC electric field, rather than a steady
AC field. When a pulsating field is applied, the forces acting on
organelles 24 and 26 have a "hammering" effect, whereby pulsed forces
beat on the intracellular organelles towards the neck 22 from both
sub-cells 14 and 16, thereby increasing the probability of breaking cell
membrane 11 in the vicinity of neck 22.
[0061] A very important element, which is very susceptible to the special
fields that develop within the dividing cells is the microtubule spindle
that plays a major role in the division process. In FIG. 4, a dividing
cell 10 is illustrated, at an earlier stage as compared to FIGS. 3A and
3B, under the influence of external TC fields (e.g., alternating fields
in the frequency range of about 100 kHz to about 300 kHz), generally
indicated as lines 100, with a corresponding spindle mechanism generally
indicated at 120. The lines 120 are microtubules that are known to have a
very strong dipole moment. This strong polarization makes the tubules
susceptible to electric fields. Their positive charges are located at the
two centrioles while two sets of negative poles are at the center of the
dividing cell and the other pair is at the points of attachment of the
microtubules to the cell membrane, generally indicated at 130. This
structure forms sets of double dipoles and therefore they are susceptible
to fields of different directions. It will be understood that the effect
of the TC fields on the dipoles does not depend on the formation of the
bridge (neck) and thus, the dipoles are influenced by the TC fields prior
to the formation of the bridge (neck).
[0062] Since the present apparatus (as will be described in greater detail
below) utilizes insulated electrodes, the above-mentioned negative
effects obtained when conductive electrodes are used, i.e., ion
concentration changes in the cells and the formation of harmful agents by
electrolysis, do not occur when the present apparatus is used. This is
because, in general, no actual transfer of charges takes place between
the electrodes and the medium and there is no charge flow in the medium
where the currents are capacitive, i.e., are expressed only as rotation
of charges, etc.
[0063] Turning now to FIG. 5, the TC fields described above that have been
found to advantageously destroy tumor cells are generated by an
electronic apparatus 200. FIG. 5 is a simple schematic diagram of the
electronic apparatus 200 illustrating the major components thereof The
electronic apparatus 200 generates the desired electric signals (TC
signals) in the shape of waveforms or trains of pulses. The apparatus 200
includes a generator 210 and a pair of conductive leads 220 that are
attached at one end thereof to the generator 210. The opposite ends of
the leads 220 are connected to insulated conductors 230 that are
activated by the electric signals (e.g., waveforms). The insulated
conductors 230 are also referred to hereinafter as isolects 230.
Optionally and according to another exemplary embodiment, the apparatus
200 includes a temperature sensor 240 and a control box 250 which are
both added to control the amplitude of the electric field generated so as
not to generate excessive heating in the area that is treated.
[0064] The generator 210 generates an alternating voltage waveform at
frequencies in the range from about 50 kHz to about 500 kHz (preferably
from about 100 kHz to about 300 kHz) (i.e., the TC fields). The required
voltages are such that the electric field intensity in the tissue to be
treated is in the range of about 0.1 V/cm to about 10 V/cm. To achieve
this field, the actual potential difference between the two conductors in
the isolects 230 is determined by the relative impedances of the system
components, as described below.
[0065] When the control box 250 is included, it controls the output of the
generator 210 so that it will remain constant at the value preset by the
user or the control box 250 sets the output at the maximal value that
does not cause excessive heating, or the control box 250 issues a warning
or the like when the temperature (sensed by temperature sensor 240)
exceeds a preset limit.
[0066] The leads 220 are standard isolated conductors with a flexible
metal shield, preferably grounded so that it prevents the spread of the
electric field generated by the leads 220. The isolects 230 have specific
shapes and positioning so as to generate an electric field of the desired
configuration, direction and intensity at the target volume and only
there so as to focus the treatment.
[0067] The specifications of the apparatus 200 as a whole and its
individual components are largely influenced by the fact that at the
frequency of the present TC fields (50 kHz-500 kHz), living systems
behave according to their "Ohmic", rather than their dielectric
properties. The only elements in the apparatus 200 that behave
differently are the insulators of the isolects 230 (see FIGS. 7-9). The
isolects 200 consist of a conductor in contact with a dielectric that is
in contact with the conductive tissue thus forming a capacitor.
[0068] The details of the construction of the isolects 230 is based on
their electric behavior that can be understood from their simplified
electric circuit when in contact with tissue as generally illustrated in
FIG. 6. In the illustrated arrangement, the electric field distribution
between the different components is determined by their relative electric
impedance, i.e., the fraction of the field on each component is given by
the value of its impedance divided by the total circuit impedance. For
example, the potential drop on element ? V.sub.A=A/(A+B+C+D+E). Thus, for
DC or low frequency AC, practically all the potential drop is on the
capacitor (that acts as an insulator). For relatively very high
frequencies, the capacitor practically is a short and therefore,
practically all the field is distributed in the tissues. At the
frequencies of the present TC fields (e.g., 50 kHz to 500 kHz), which are
intermediate frequencies, the impedance of the capacitance of the
capacitors is dominant and determines the field distribution. Therefore,
in order to increase the effective voltage drop across the tissues (field
intensity), the impedance of the capacitors is to be decreased (i.e.,
increase their capacitance). This can be achieved by increasing the
effective area of the "plates" of the capacitor, decrease the thickness
of the dielectric or use a dielectric with high dielectric constant.
There a number of different materials that are suitable for use in the
intended application and have high dielectric constants. For example,
some materials include: lithium niobate (LiNbO.sub.3), which is a
ferroelectric crystal and has a number of applications in optical,
pyroelectric and piezoelectric devices; yttrium iron garnet (YIG) is a
ferromagnetic crystal and magneto-optical devices, e.g., optical isolator
can be realized from this material; barium titanate (BaTiO.sub.3) is a
ferromagnetic crystal with a large electro-optic effect; potassium
tantalate (KTaO.sub.3) which is a dielectric crystal (ferroelectric at
low temperature) and has very low microwave loss and tunability of
dielectric constant at low temperature; and lithium tantalate
(LiTaO.sub.3) which is a ferroelectric crystal with similar properties as
lithium niobate and has utility in electro-optical, pyroelectric and
piezoelectric devices. It will be understood that the aforementioned
exemplary materials can be used in combination with the present device
where it is desired to use a material having a high dielectric constant.
[0069] In order to optimize the field distribution, the isolects 230 are
configured differently depending upon the application in which the
isolects 230 are to be used. There are two principle modes for applying
the present electric fields (TC fields). First, the TC fields can be
applied by external isolects and second, the TC fields can be applied by
internal isolects.
[0070] Electric fields (TC fields) that are applied by external isolects
can be of a local type or widely distributed type. The first type
includes, for example, the treatment of skin tumors and treatment of
lesions close to the skin surface. FIG. 7 illustrates an exemplary
embodiment where the isolects 230 are incorporated in a skin patch 300.
The skin patch 300 can be a self-adhesive flexible patch with one or more
pairs of isolects 230. The patch 300 includes internal insulation 310
(formed of a dielectric material) and the external insulation 260 and is
applied to skin surface 301 that contains a tumor 303 either on the skin
surface 301 or slightly below the skin surface 301. Tissue is generally
indicated at 305. To prevent the potential drop across the internal
insulation 310 to dominate the system, the internal insulation 310 must
have a relatively high capacity. This can be achieved by a large surface
area; however, this may not be desired as it will result in the spread of
the field over a large area (e.g., an area larger than required to treat
the tumor). Alternatively, the internal insulation 310 can be made very
thin and/or the internal insulation 310 can be of a high dielectric
constant. As the skin resistance between the electrodes (labeled as A and
E in FIG. 6) is normally significantly higher than that of the tissue
(labeled as C in FIG. 6) underneath it (1-10 kO vs. 0.1-1 kO), most of
the potential drop beyond the isolects occurs there. To accommodate for
these impedances (Z), the characteristics of the internal insulation 310
(labeled as B and D in FIG. 6) should be such that they have impedance
preferably under 100 kO at the frequencies of the present TC fields
(e.g., 50 kHz to 500 kHz). For example, if it is desired for the
impedance to be about 10 K Ohms, such that over 1% of the applied voltage
falls on the tissues, for isolects with a surface area of 10 mm.sup.2, at
frequencies of 200 kHz, the capacity should be on the order of 10.sup.-10
F, which means that using standard insulations with a dielectric constant
of 2-3, the thickness of the insulating layer 310 should be about 50-100
microns. An internal field 10 times stronger would be obtained with
insulators with a dielectric constant of about 20-50.
[0071] Since the insulating layer can be very vulnerable, etc., the
insulation can be replaced by very high dielectric constant insulating
materials, such as titanium dioxide (e.g., rutil), the dielectric
constant can reach values of about 200. One must also consider another
factor that effects the effective capacity of the isolects 230, namely
the presence of air between the isolects 230 and the skin. Such presence,
which is not easy to prevent, introduces a layer of an insulator with a
dielectric constant of 1.0, a factor that significantly lowers the
effective capacity of the isolects 230 and neutralizes the advantages of
the titanium dioxide (rutil), etc. To overcome this problem, the isolects
230 can be shaped so as to conform with the body structure and/or (2) an
intervening filler 270 (as illustrated in FIG. 1C), such as a gel, that
has high conductance and a dielectric constant, can be added to the
structure. The shaping can be pre-structured (see FIG. 10A) or the system
can be made sufficiently flexible so that shaping of the isolects 230 is
readily achievable. The gel can be contained in place by having an
elevated rim as depicted in FIG. 10C. The gel can be made of gelatins,
agar, etc., and can have salts dissolved in it to increase its
conductivity. FIGS. 10A-10C illustrate various exemplary configurations
for the isolects 230. The exact thickness of the gel is not important so
long as it is of sufficient thickness that the gel layer does not dry out
during the treatment. In one exemplary embodiment, the thickness of the
gel is about 0.5 mm to about 2 mm.
[0072] In order to achieve the desirable features of the isolects 230, the
dielectric coating of each should be very thin, for example from between
1-50 microns. Since the coating is so thin, the isolects 230 can easily
be damaged mechanically. This problem can be overcome by adding a
protective feature to the isolect's structure so as to provide desired
protection from such damage. For example, the isolect 230 can be coated,
for example, with a relatively loose net 340 that prevents access to the
surface but has only a minor effect on the effective surface area of the
isolect 230 (i.e., the capacity of the isolects 230 (cross section
presented in FIG. 12B). The loose net 340 does not effect the capacity
and ensures good contact with the skin, etc. The loose net 340 can be
formed of a number of different materials; however, in one exemplary
embodiment, the net 340 is formed of nylon, polyester, cotton, etc.
Alternatively, a very thin conductive coating 350 can be applied to the
dielectric portion (insulating layer) of the isolect 230. One exemplary
conductive coating is formed of a metal and more particularly of gold.
The thickness of the coating 350 depends upon the particular application
and also on the type of material used to form the coating 350; however,
when gold is used, the coating has a thickness from about 0.1 micron to
about 0.1 mm. Furthermore, the rim illustrated in FIG. 10 can also
provide some mechanical protection.
[0073] However, the capacity is not the only factor to be considered. The
following two factors also influence how the isolects 230 are
constructed. The dielectric strength of the internal insulating layer 310
and the dielectric losses that occur when it is subjected to the TC
field, i.e., the amount of heat generated. The dielectric strength of the
internal insulation 310 determines at what field intensity the insulation
will be "shorted" and cease to act as an intact insulation. Typically,
insulators, such as plastics, have dielectric strength values of about
100V per micron or more. As a high dielectric constant reduces the field
within the internal insulator 310, a combination of a high dielectric
constant and a high dielectric strength gives a significant advantage.
This can be achieved by using a single material that has the desired
properties or it can be achieved by a double layer with the correct
parameters and thickness. In addition, to further decreasing the
possibility that the insulating layer 310 will fail, all sharp edges of
the insulating layer 310 should be eliminated as by rounding the corners,
etc., as illustrated in FIG. 10D using conventional techniques.
[0074] FIGS. 8 and 9 illustrate a second type of treatment using the
isolects 230, namely electric field generation by internal isolects 230.
A body to which the isolects 230 are implanted is generally indicated at
311 and includes a skin surface 313 and a tumor 315. In this embodiment,
the isolects 230 can have the shape of plates, wires or other shapes that
can be inserted subcutaneously or a deeper location within the body 311
so as to generate an appropriate field at the target area (tumor 315).
[0075] It will also be appreciated that the mode of isolects application
is not restricted to the above descriptions. In the case of tumors in
internal organs, for example, liver, lung, etc., the distance between
each member of the pair of isolects 230 can be large. The pairs can even
by positioned opposite sides of a torso 410, as illustrated in FIG. 11.
The arrangement of the isolects 230 in FIG. 11 is particularly useful for
treating a tumor 415 associated with lung cancer. In this embodiment, the
electric fields (TC fields) spread in a wide fraction of the body.
[0076] In order to avoid overheating of the treated tissues, a selection
of materials and field parameters is needed. The isolects insulating
material should have minimal dielectric losses at the frequency ranges to
be used during the treatment process. This factor can be taken into
consideration when choosing the particular frequencies for the treatment.
The direct heating of the tissues will most likely be dominated by the
heating due to current flow (given by the I*R product).
[0077] The effectiveness of the treatment can be enhanced by an
arrangement of isolects 230 that focuses the field at the desired target
while leaving other sensitive areas in low field density (i.e., protected
areas). The proper placement of the isolects 230 over the body can be
maintained using any number of different techniques, including using a
suitable piece of clothing that keeps the isolects at the appropriate
positions. FIG. 13 illustrates such an arrangement in which an area
labeled as "P" represents a protected area. The lines of field force do
not penetrate this protected area and the field there is much smaller
than near the isolects 230 where target areas can be located and treated
well. In contrast, the field intensity near the four poles is very high.
[0078] The following Example serves to illustrate an exemplary application
of the present apparatus and application of TC fields; however, this
Example is not limiting and does not limit the scope of the present
invention in any way.
EXAMPLE
[0079] To demonstrate the effectiveness of electric fields having the
above described properties (e.g., frequencies between 50 kHz and 500 kHz)
in destroying tumor cells, the electric fields were applied to treat mice
with malignant melanoma tumors. Two pairs of isolects 230 were positioned
over a corresponding pair of malignant melanomas. Only one pair was
connected to the generator 210 and 200 kHz alternating electric fields
(TC fields) were applied to the tumor for a period of 6 days. One
melanoma tumor was not treated so as to permit a comparison between the
treated tumor and the non-treated tumor. After treatment for 6 days, the
pigmented melanoma tumor remained clearly visible in the non-treated side
of the mouse, while, in contrast, no tumor is seen on the treated side of
the mouse. The only areas that were visible discernable on the skin were
the marks that represented the points of insertion of the isolects 230.
The fact that the tumor was eliminated at the treated side was further
demonstrated by cutting and inversing the skin so that its inside face
was exposed. Such a procedure indicated that the tumor has been
substantially, if not completely, eliminated on the treated side of the
mouse. The success of the treatment was also further verified by
pathhistological examination.
[0080] The present inventor has thus uncovered that electric fields having
particular properties can be used to destroy dividing cells or tumors
when the electric fields are applied to using an electronic device. More
specifically, these electric fields fall into a special intermediate
category, namely bio-effective fields that have no meaningful stimulatory
and no thermal effects, and therefore overcome the disadvantages that
were associated with the application of conventional electric fields to a
body. It will also be appreciated that the present apparatus can further
include a device for rotating the TC field relative to the living tissue.
For example and according to one embodiment, the alternating electric
potential applies to the tissue being treated is rotated relative to the
tissue using conventional devices, such as a mechanical device that upon
activation, rotates various components of the present system.
[0081] While the invention has been particularly shown and described with
reference to preferred embodiments thereof, it will be understood by
those skilled in the art that various changes in form and details can be
made without departing from the spirit and scope of the invention.
* * * * *